Atosiban: Top Pharmaceutical Grade Uterine Contractions Inhibitor

SKU:
Procurenet
Short description

Atosiban, a superior pharmaceutical-grade receptor antagonist, is designed to mitigate uterine contractions by inhibiting oxytocin and vasopressin V1A receptor pathways. Key features of the product include:

  • Uterine Contraction Inhibition: Effectively blocks oxytocin and vasopressin V1A receptor pathways, reducing uterus tension.
  • Superior Quality: Pharmaceutical-grade implying high-quality and rigorous safety standards.
  • Global Applicability: Suitable for multiple markets worldwide.

Atosiban is primarily used for managing preterm labor, reducing uterine contractions, and preventing premature birth. It should be administered under trained medical supervision.

Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years
Description

Atosiban - The Ultimate Pharmaceutical Grade Uterine Contractions Inhibitor

Atosiban, a world-class combined receptor antagonist for oxytocin and vasopressin V1A, has been heralded for its potent ability to inhibit uterine contractions. Leveraging the industry's most advanced pharmaceutical technology, this powerful drug has the capacity to block both oxytocin and vasopressin V1A receptor pathways, offering formidable relief for uterine contractions.

As part of the pharmacological class of oxytocin antagonists, Atosiban boasts an intricate design specifically for tempering the activity of oxytocin – a hormone popularly known for instigating uterine contractions. It accomplishes this via a unique, effective mechanism of action that blocks the pathways of oxytocin and vasopressin V1A receptors, thereby curtailing the progression of uterine contractions.

Atosiban maintains a high level of compliance with strict pharmaceutical-grade regulations. This assures users of both its safety and effectiveness, offering peace of mind to manufacturers and end-users alike.

  • CAS Number: 90779-69-4
  • IUPAC Name: 1-(3-mercaptopropanoic acid)-O-(2-O-methyltyrosine)-4-threonine-8-ornithineoxytocin
  • Molecular Formula: C43H67N11O12S2
  • Molecular Weight: 994.2 g/mol
  • Canonical SMILES: CCNC(=O)CNC(=O)CNC(=O)[C@@H]1CCC(=O)N1C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CSSCC(C(=O)O)NC(=O)[C@@H]3CCC(=O)N3)N
  • InChI strings: InChI=1S/C43H67N11O12S2/c1-23(2)35-42(68)49-15-5-9-31(49)41(67)52-29(17-25-7-6-16-45-25)39(65)50-13-3-4-24(50)40(66)51-18-26-11-8-32(46-26)53-37(63)19-27(55)33-44-12-10-30(48)54-34(33)36(43(69)70)56-38(64)20-28-14-28/h6-7,16,23-24,27,29-31,33-36,46,56H,3-5,8-15,17-20H2,1-2H3,(H,44,48)(H,52,67)(H,53,63)(H,54,64)(H,55,68)(H,69,70)/t24-,27-,29-,30-,31-,33-,34-,35-,36-/m0/s1
  • Density: 1.3 g/cm^3
  • Solubility: Soluble in DMSO, water
  • Pharmacological Class: Oxytocin antagonists
  • Boiling Point: 1563.7±65.0 °C at 760 mmHg
  • Melting Point: N/A
  • Flash Point: 901.2±34.3 °C
  • Routes of Exposure: Injection
  • Hazard Statements: H302 - Harmful if swallowed, H315 - Causes skin irritation, H319 - Causes serious eye irritation
  • Precautionary Statements: P280 - Wear protective gloves/protective clothing/eye protection/face protection

Atosiban is an ideal choice for businesses across North America, Central/South America, Western Europe, Eastern Europe, Australasia, Asia, Middle East, and Africa. For comprehensive evaluation and testing, samples of Atosiban are readily available.

Leverage the incredible capabilities of Atosiban to stand out in the market. Assured of successful business growth, Atosiban will help you offer your clients a powerful inhibitor of uterine contractions.

All categories
Items (0)
No Record Found

Your Shopping Bag Is Empty

Filters
Procurenet Limited
Log in | Sign Up